MedTrace Logo

Perioperative Telemonitoring to Optimize Cancer Care and Outcomes

NCT04986566 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2026-03-27

Study results available
· View outcomes & findings →

Summary

This study aims to see whether an at-home monitoring program that collects health, symptoms, and quality of life data in real-time can be included as part of the care of surgery patients in order to provide better recovery. Patient-generated health data (weight, temperature, oxygen level, heart rate, blood pressure, daily steps, symptoms, quality of life) using at-home monitoring devices (thermometer, a pulse oximeter, a digital scale and a Vivofit 4 watch) and smart device applications are used more and more to measure value and quality in cancer care. However, measuring patient-generated health data is not currently part of standard care following cancer surgery. An at-home monitoring program may improve the care of patients after hospital discharge from surgery and may help reduce complications by identifying issues early.

Conditions

  • Malignant Digestive System Neoplasm

Interventions

OTHER

Best Practice

Use standard reporting procedures

BEHAVIORAL

Health Education

Use Aetonixx app

OTHER

Medical Device Usage and Evaluation

Wear Vivofit 4

OTHER

Quality-of-Life Assessment

Complete questionnaires

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Laleh Melstrom · City of Hope Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-19
Primary Completion
2023-08-31
Completion
2027-02-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04986566 on ClinicalTrials.gov